Narcisa Mandras Selected Research

Narcisa Mandras Research Topics

10	Infections 02/2024 - 12/2011
4	Wounds and Injuries (Trauma) 01/2023 - 01/2015
2	Aspergillosis 10/2023 - 10/2021
2	Hypoxia (Hypoxemia) 01/2023 - 02/2021
2	Candidiasis (Moniliasis) 01/2023 - 08/2016
2	Mycoses (Diseases, Fungus) 08/2021 - 08/2019
1	Persistent Infection 01/2021
1	Drug-Related Side Effects and Adverse Reactions 08/2019
1	Tinea Capitis 01/2019
1	Invasive Candidiasis 12/2011
1	Invasive Fungal Infections 09/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2004

4	AzolesIBA 10/2023 - 09/2010
4	Volatile Oils (Essential Oils)IBA 01/2023 - 08/2016
3	Caspofungin (Cancidas)FDA Link 01/2023 - 09/2010
3	ChitosanIBA 01/2022 - 01/2015
2	SilverIBA 02/2024 - 08/2023
2	Itraconazole (Sporanox)FDA LinkGeneric 10/2023 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 08/2023 - 02/2021
2	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 10/2015
2	Oxygen (Dioxygen)IBA 01/2022 - 02/2021
2	TriazolesIBA 10/2021 - 01/2021
2	Antifungal AgentsIBA 08/2019 - 08/2016
1	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2023
1	IonsIBA 08/2023
1	MetalsIBA 08/2023
1	Erythromycin (Erycette)FDA LinkGeneric 01/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2023
1	Anidulafungin FDA Link 01/2023
1	Anti-Infective Agents (Microbicides)IBA 01/2023
1	2H,3H-decafluoropentaneIBA 02/2021
1	Biopolymers (Biopolymer)IBA 02/2021
1	Polysaccharides (Glycans)IBA 02/2021
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2021
1	ImidazolesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Voriconazole (Vfend)FDA LinkGeneric 10/2015
1	ThiamphenicolIBA 10/2004

3	Therapeutics 01/2019 - 10/2015